Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry

Table 4

Patient characteristics and LOS for patients admitted with HN who corrected with initial HN therapy.

	Relapse (n = 61)	No relapse (n = 49)
[Na^+], mmol/L	128.0 (4.0)	127.0 (5.0)
at time of correction, mmol/	132.0 (2.0)	132.0 (2.0)
BUN, mg/dL	17.0 (17.0)	16.0 (16.0)
Cr, mg/dL	1.0 (0.5)	1.0 (0.9)
BUN:Cr ratio	19.1 (9.6)	17.4 (11.4)
Tbili, µmol/L	4.8 (7.3)	4.3 (6.7)
INR, s	1.8 (0.8)	1.8 (0.5)
Alb, g/doll	2.6 (0.9)	2.8 (0.7)
MELD score at correction	20.9 (6.6)	21.9 (11.3)
LOS,	9 (6.0)	6 (5.0)
LOS until correction, d	3 (2.0)	3 (1.0)
LOS after correction,	6 (5.0)	2 (3.0)
Death/ hospice, n (%)	5 (8)	5 (10)

< 0.05.
Values for sodium concentration ([Na⁺]), [Na⁺] at time of correction, blood urea nitrogen (BUN), creatinine (Cr), BUN:CR ratio, total bilirubin (Tbili), albumin (Alb), international normalized ratio (INR), Model for End-Stage Liver Disease (MELD) score at correction, length of stay (LOS), LOS until correction, and LOS after correction are median (interquartile range). HN, hyponatremia.